APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 209 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,080,000 | -38.1% | 2,000,000 | +48.3% | 4.44% | -35.5% |
| Q2 2023 | $122,893,900 | +136896.3% | 1,349,000 | -0.8% | 6.88% | +16.5% |
| Q1 2023 | $89,706 | +10.0% | 1,360,000 | -13.8% | 5.91% | +8.3% |
| Q4 2022 | $81,540 | -99.9% | 1,576,872 | +6.7% | 5.46% | -22.7% |
| Q3 2022 | $100,947,000 | +135.0% | 1,478,000 | +55.6% | 7.06% | +117.2% |
| Q2 2022 | $42,959,000 | -24.8% | 950,000 | -15.6% | 3.25% | -26.0% |
| Q1 2022 | $57,161,000 | +93.4% | 1,125,000 | +80.0% | 4.39% | +149.7% |
| Q4 2021 | $29,550,000 | -3.1% | 625,000 | -32.4% | 1.76% | +41.9% |
| Q3 2021 | $30,488,000 | -43.2% | 925,000 | +8.8% | 1.24% | -32.1% |
| Q2 2021 | $53,720,000 | -32.9% | 850,000 | -54.5% | 1.82% | +2.3% |
| Q1 2021 | $80,075,000 | -25.0% | 1,866,108 | 0.0% | 1.78% | -29.8% |
| Q4 2020 | $106,741,000 | +89.6% | 1,866,108 | 0.0% | 2.54% | +17.3% |
| Q3 2020 | $56,300,000 | -16.6% | 1,866,108 | -9.7% | 2.16% | -15.9% |
| Q2 2020 | $67,479,000 | +11.2% | 2,066,108 | -8.8% | 2.58% | -8.7% |
| Q1 2020 | $60,709,000 | -26.6% | 2,266,108 | -16.1% | 2.82% | -14.5% |
| Q4 2019 | $82,674,000 | +15.3% | 2,700,000 | -9.3% | 3.30% | -24.4% |
| Q3 2019 | $71,692,000 | -4.6% | 2,976,000 | +0.3% | 4.36% | +1.1% |
| Q2 2019 | $75,161,000 | +7.1% | 2,966,108 | -17.6% | 4.32% | -9.0% |
| Q1 2019 | $70,200,000 | +18.2% | 3,600,000 | -20.0% | 4.74% | -1.6% |
| Q4 2018 | $59,388,000 | -19.9% | 4,502,498 | +7.9% | 4.82% | 0.0% |
| Q3 2018 | $74,187,000 | -21.8% | 4,172,498 | -3.2% | 4.82% | -31.3% |
| Q2 2018 | $94,875,000 | +5.0% | 4,312,498 | +5.5% | 7.02% | +4.2% |
| Q1 2018 | $90,390,000 | +10.5% | 4,088,229 | +8.5% | 6.74% | -21.3% |
| Q4 2017 | $81,782,000 | – | 3,768,757 | – | 8.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |